mitoxantrone has been researched along with Agammaglobulinemia in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Agammaglobulinemia: An immunologic deficiency state characterized by an extremely low level of generally all classes of gamma-globulin in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Patients with prolonged memory B-cell depletion after RTX, previous mitoxantrone history, hypo-IgG at baseline, or obesity were at risk of developing RTX-induced hypogammaglobulinemia." | 4.12 | Rituximab-Induced Hypogammaglobulinemia and Risk of Infection in Neuromyelitis Optica Spectrum Disorders: A 14-Year Real-Life Experience. ( Hyun, JW; Kim, HJ; Kim, KH; Kim, SH; Park, NY, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, SH | 1 |
| Park, NY | 1 |
| Kim, KH | 1 |
| Hyun, JW | 1 |
| Kim, HJ | 1 |
1 other study available for mitoxantrone and Agammaglobulinemia
| Article | Year |
|---|---|
Rituximab-Induced Hypogammaglobulinemia and Risk of Infection in Neuromyelitis Optica Spectrum Disorders: A 14-Year Real-Life Experience.
Topics: Agammaglobulinemia; Humans; Immunoglobulin G; Immunologic Factors; Mitoxantrone; Neuromyelitis Optic | 2022 |